Literature DB >> 7109836

Influence of dopamine agonists on plasma and brain levels of homovanillic acid.

K S Kendler, G R Heninger, R H Roth.   

Abstract

The response of the plasma dopamine (DA) metabolite, homovanillic acid (HVA), to two DA agonists was investigated in the rat. Apomorphine administered i.p. (2 mg/kg) produced, within one hour, a significant decrease in plasma HVA. The response of plasma HVA to apomorphine was also investigated after pretreatment with debrisoquin, a drug which selectively blocks peripheral HVA production by inhibition of MAO. Pretreatment with debrisoquin did not significantly alter the decrement in plasma HVA produced by apomorphine indicating that a substantial portion of the plasma HVA response to apomorphine is due to the drug's action on brain. Bromocriptine (2 mg/kg) was also found to produce a significant decrease in plasma HVA. Since the response of brain HVA to DA agonists reflects the sensitivity of the DA receptor, the plasma HVA response to DA agonists might be a practical method of assessing brain DA receptor sensitivity in humans.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7109836     DOI: 10.1016/0024-3205(82)90447-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.

Authors:  E Suzuki; S Kanba; H Koshikawa; M Nibuya; G Yagi; M Asai
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

2.  Plasma amino acids and neopterin in healthy persons with Down's syndrome.

Authors:  A W Coppus; D Fekkes; W M A Verhoeven; S Tuinier; J I M Egger; C M van Duijn
Journal:  J Neural Transm (Vienna)       Date:  2007-03-31       Impact factor: 3.575

3.  Diagnosis of pheochromocytoma in the setting of Parkinson disease.

Authors:  Shyamal H Mehta; Rajan Prakash; L Michael Prisant; Carlos M Isales; John C Morgan; Hadyn Williams; Kapil D Sethi
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

4.  Prediction of changes in memory performance by plasma homovanillic acid levels in clozapine-treated patients with schizophrenia.

Authors:  Tomiki Sumiyoshi; A Roy; C-H Kim; K Jayathilake; M A Lee; C Sumiyoshi; H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2004-06-04       Impact factor: 4.530

5.  Assessment of central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration.

Authors:  M A Riddle; J F Leckman; D J Cohen; M Anderson; S I Ort; K A Caruso; B A Shaywitz
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

6.  The effect of chronic chlorpromazine administration on monoamine levels in various regions of rat brain.

Authors:  M H Baf; M N Subhash; K M Lakshmana; B S Rao
Journal:  Neurochem Res       Date:  1995-01       Impact factor: 3.996

7.  Heterogeneity in plasma homovanillic Acid levels in schizophreniform disorder.

Authors:  N Pradhan; C Harihar; P Das; C Andrade
Journal:  Indian J Psychiatry       Date:  1992-04       Impact factor: 1.759

8.  Monoamine and genome-wide DNA methylation investigation in behavioral addiction.

Authors:  Yui Asaoka; Moojun Won; Tomonari Morita; Emi Ishikawa; Young-A Lee; Yukiori Goto
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.